Upgrade to SI Premium - Free Trial

Merck (MRK) PT Raised to $145 at Argus

August 11, 2026 7:12 AM
Argus analyst Jasper Hellweg raised the price target on Merck (NYSE: MRK) to $145.00 (from $130.00) while maintaining a Buy ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change